Volume : 10, Issue : 08, August – 2023

Title:

27.DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF MITAPIVAT IN BULK AND PHARMACEUTICAL DOSAGE FORM

Authors :

Siva Jyothi Buggana, Nerendla Ramya, Bhooma Shirisha, R. Prasanthi, Mamatha Tirunagari *

Abstract :

A simple, rapid, precise, sensitive and reproducible reverse phase high performance liquid chromatography (RP-HPLC) method has been developed for the quantitative analysis of Mitapivat in pharmaceutical dosage form. Chromatographic separation of Mitapivat was achieved on Waters Alliance-e2695, by using Zorbax SB C18 (250×4.6mm, 5µ) column and the mobile phase containing ACN and Water in the ratio of 80:20% v/v. The flow rate was 1.0 ml/min; detection was carried out by absorption at 278nm using a photodiode array detector at ambient temperature. The number of theoretical plates and tailing factor for Mitapivat were NLT 2000 and should not more than 2 respectively. %Relative standard deviation of peak areas of all measurements always less than 2.0. The proposed method was validated according to ICH guidelines. The method was found to be simple, economical, suitable, precise, accurate & robust method for quantitative analysis of Mitapivat.
Key words: HPLC Method, Mitapivat, ICH guidelines, Validation, Degradation studies.

Cite This Article:

Please cite this article in press Tirunagari Mamatha et al, Development And Validation Of Rp-Hplc Method For Estimation Of Mitapivat In Bulk And Pharmaceutical Dosage Form, Indo Am. J. P. Sci, 2023; 10 (08).

Number of Downloads : 10

References:

1. Baldwin C, Pandey J, Olarewaju O. Hemolytic Anemia. [Updated 2023 Jul 24]. In: Stat Pearls [Internet]. Publishing; 2023,Jan, Availablefrom: https://www.ncbi.nlm.nih.gov/books/NBK558904/
2. Sigbjørn Berentsen MD, Wilma Barcellini MD. Autoimmune Hemolytic Anemias. New England Journal of Medicine, 2021, 1407-1419. DOI: 10.1056/NEJMra2033982
3. Quentin AH, Sigbjørn B. Defining autoimmune hemolytic anemia. a systematic review of the terminology used for diagnosis and treatment. Blood Advances, 2019, 3 (12), 1897–1906.
4. Samkari H, van Beers EJ. Mitapivat, a novel pyruvate kinase activator for the treatment of hereditary hemolytic anemias. Ther Adv Hematol, 2021, 21-27.
5. Perez EA, Weilbaecher K. Aromatase inhibitors and bone loss. Oncology (Williston Park), 2006 20(9), 1029-1039.
6. Matte A, Federti E, Kung C, Kosinski PA, Narayanaswamy R, Russo R, Federico G, Carlomagno F, Desbats MA, Salviati L, Leboeuf C, Valenti MT, Turrini F, Janin A, Yu S, Beneduce E, Ronseaux S, Iatcenko I, Dang L, Ganz T, Jung CL, Iolascon A, Brugnara C, De Franceschi L. The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a beta-thalassemia mouse model. J Clin Invest, 2021, 131(10), 01-20.
7. Mitapivat. drugbank.com/drugs/DB16236.
8. Validation of Analytical Proceudures, ICH Harmonised Tripatite Guidelines,Q2 B 1997
9. Dhanashri Parasram Fand, A Review On Analytical Method Development, IJCRT, 2022, 10(1). 1-14.
10. Geetha G, Karanam Naga Ganika Raju B, Vignesh Kumar M, Gnana Raja M. Analytical Method Validation: An Updated Review. International Journal of advances in Pharmacy, Biology and Chemistry, 2012, 1(1), 201-212.
11. Ramole Rina, Mohini Baile, Ashish J. A Review: Analytical Method Development and Validation. Sys Rev Pharm, 2021, 12(8), 450-454.
12. Bhagat R, Saudagar RB. A Review on Analytical method Development and Validation. JDDT [Internet]. ,2019, 9(3-s):1064-7.Availablefrom: https://jddtonline.info/index.php/jddt/article/view/2957
13. International Conference on Harmonization (ICH), Validation of analytical procedure: Text and methodology, Harmonized tripartite guideline, Q2 (R1), Geneva, 2005
14. Skoog DA, Holler FJ, Crouch SR, Principles of Instrumental Analysis, 6th Ed, Baba barkahanath printers, Haryana, 2007, 816-855.
15. Guidance for Industry, Q2 (R1) Validation of Analytical Procedures: Methodology, U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Biologics Evaluation and Research (CBER), International Conference on Harmonization, Geneva, November 2005.
16. Akash D, Rajmane, Komal P. A Review of HPLC Method Development and Validation as per ICH Guidelines. Asian Journal of Pharmaceutical Analysis, 2023, 13(2), 143-151.